Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.
about
Mast cells as effectors in atherosclerosisAllergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice.Human Mesenchymal Stem Cell-Derived Microvesicles Prevent the Rupture of Intracranial Aneurysm in Part by Suppression of Mast Cell Activation via a PGE2-Dependent Mechanism.Mast cells in human and experimental cardiometabolic diseases.Interaction between allergic asthma and atherosclerosis.Protective Effect of Mesenchymal Stem Cells Against the Development of Intracranial Aneurysm Rupture in Mice.
P2860
Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmaceutical stabilization o ...... otein receptor-deficient mice.
@en
Pharmaceutical stabilization o ...... otein receptor-deficient mice.
@nl
type
label
Pharmaceutical stabilization o ...... otein receptor-deficient mice.
@en
Pharmaceutical stabilization o ...... otein receptor-deficient mice.
@nl
prefLabel
Pharmaceutical stabilization o ...... otein receptor-deficient mice.
@en
Pharmaceutical stabilization o ...... otein receptor-deficient mice.
@nl
P2093
P2860
P1433
P1476
Pharmaceutical stabilization o ...... otein receptor-deficient mice.
@en
P2093
Blandine Secco
Galina K Sukhova
Guo-Ping Shi
Sara Sjöberg
Viviane Tia
P2860
P304
P356
10.1016/J.ATHEROSCLEROSIS.2013.05.025
P577
2013-06-07T00:00:00Z